Tapewire

Nasdaq · USD

MRNA

Moderna, Inc.

Export transactions ↓
Tapewire entity
2025
SEC CIK
0001682852
Parsed reports
1,064

Last 12 months

Inside the activity.

0 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202600
Feb 202601
Mar 202601
Apr 202600
May 202603
Jun 202602
Jul 202601
Aug 202604
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 29, 2022 Filed Jul 1, 2022 23:30 UTC SaleCommon Stock 10,000 $140.47 $1,404,700.00
Disclosure

SEC source: 0000899243-22-024806 · doc4.xml · nonDerivative · entry 1

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,517,209

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021, as amended on March 11, 2022.

Read SEC document
June 24, 2022 Filed Jun 27, 2022 21:11 UTC
Hoge StephenPresident
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0001127602-22-018179 · form4.xml · derivative · entry 8

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,972

Underlying: Common Stock · 5,000 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 24, 2022 Filed Jun 27, 2022 21:11 UTC
Hoge StephenPresident
SaleCommon Stock 5,000 $143.98 $719,900.00
Disclosure

SEC source: 0001127602-22-018179 · form4.xml · nonDerivative · entry 4

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,624,231

Read SEC document
June 24, 2022 Filed Jun 27, 2022 21:11 UTC
Hoge StephenPresident
Exercise / conversionCommon Stock 5,000 $10.90 $54,500.00
Disclosure

SEC source: 0001127602-22-018179 · form4.xml · nonDerivative · entry 3

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,629,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · derivative · entry 20

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,187,155

Underlying: Common Stock · 40,000 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F19 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 10,000 $135.96 $1,359,600.00
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 17

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,834,880

F16 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2018, as amended on September 16, 2019.

F17 · ownership.nature: These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 200 $143.54 $28,708.00
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 16

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,411,946

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F15 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.52 to $143.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 1,487 $143.10 $212,789.70
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 15

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,412,146

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F14 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.51 to $143.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 12,879 $141.84 $1,826,757.36
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 14

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,413,633

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F13 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.50 to $142.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 14,866 $141.03 $2,096,551.98
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 13

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,426,512

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.48 to $141.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 4,768 $140.05 $667,758.40
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 12

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,441,378

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.46 to $140.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 2,177 $138.88 $302,341.76
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 11

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,446,146

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.38 to $139.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 1,003 $137.88 $138,293.64
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 10

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,448,323

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.28 to $138.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 2,620 $136.93 $358,756.60
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 9

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,449,326

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.25 to $137.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 23, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionCommon Stock 40,000 $0.99 $39,600.00
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 8

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,451,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

Read SEC document
June 23, 2022 Filed Jun 27, 2022 21:11 UTC
Hoge StephenPresident
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0001127602-22-018179 · form4.xml · derivative · entry 7

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,972

Underlying: Common Stock · 5,000 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 23, 2022 Filed Jun 27, 2022 21:11 UTC
Hoge StephenPresident
SaleCommon Stock 5,000 $135.96 $679,800.00
Disclosure

SEC source: 0001127602-22-018179 · form4.xml · nonDerivative · entry 2

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,624,231

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

Read SEC document
June 23, 2022 Filed Jun 27, 2022 21:11 UTC
Hoge StephenPresident
Exercise / conversionCommon Stock 5,000 $10.90 $54,500.00
Disclosure

SEC source: 0001127602-22-018179 · form4.xml · nonDerivative · entry 1

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,629,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:42 UTC SaleCommon Stock 10,000 $127.69 $1,276,900.00
Disclosure

SEC source: 0000899243-22-024101 · doc4.xml · nonDerivative · entry 1

AFEYAN NOUBAR · CIK 0001222012 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,527,209

F1 · kind: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021, as amended on March 11, 2022.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · derivative · entry 19

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,227,155

Underlying: Common Stock · 40,000 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F19 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 601 $139.74 $83,983.74
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 7

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,411,946

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.67 to $139.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 6,343 $139.05 $881,994.15
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 6

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,412,547

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.66 to $139.63. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 11,785 $138.16 $1,628,215.60
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 5

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,418,890

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.65 to $138.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 8,074 $137.03 $1,106,380.22
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 4

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,430,675

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.56 to $137.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 6,697 $136.01 $910,858.97
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 3

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,438,749

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.55 to $136.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 6,500 $131.06 $851,890.00
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 2

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,445,446

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.70 to $131.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 20:02 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionCommon Stock 40,000 $0.99 $39,600.00
Disclosure

SEC source: 0001127602-22-018120 · form4.xml · nonDerivative · entry 1

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,451,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

Read SEC document
June 16, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · derivative · entry 16

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,267,155

Underlying: Common Stock · 40,000 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F15 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 16, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 10,000 $124.29 $1,242,900.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 13

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,844,880

F12 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2018, as amended on September 16, 2019.

F13 · ownership.nature: These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.

Read SEC document
June 16, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 11,195 $120.69 $1,351,124.55
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 12

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,411,946

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.41 to $121.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 16, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 15,005 $119.85 $1,798,349.25
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 11

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,423,141

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.40 to $120.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 16, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 13,800 $119.16 $1,644,408.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 10

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,438,146

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.38 to $119.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 16, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionCommon Stock 40,000 $0.99 $39,600.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 9

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,451,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 16:03 UTC
Burton PaulChief Medical Officer
GrantRestricted Stock Units · Derivative 10,990 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-22-017895 · form4.xml · derivative · entry 4

Burton Paul · CIK 0001869869 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,990

Underlying: Common Stock · 10,990 shares

Expires not disclosed

F4 · derivative.exercise_date: 50% of the shares subject to this restricted stock unit award will vest on June 16, 2025 and the remaining 50% will vest on June 16, 2026, subject to the recipient's continued service.

F4 · derivative.expiration_date: 50% of the shares subject to this restricted stock unit award will vest on June 16, 2025 and the remaining 50% will vest on June 16, 2026, subject to the recipient's continued service.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 16:03 UTC
Burton PaulChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 19,772 $0.00 Strike: $121.08 $0.00
Disclosure

SEC source: 0001127602-22-017895 · form4.xml · derivative · entry 3

Burton Paul · CIK 0001869869 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,772

Underlying: Common Stock · 19,772 shares

Expires 2032-06-16

F3 · derivative.exercise_date: 50% of this option will vest and become exercisable on June 16, 2025 and the remaining 50% will vest and become exercisable on June 16, 2026, subject to the recipient's continued service.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 16:03 UTC
Burton PaulChief Medical Officer
GrantRestricted Stock Units · Derivative 3,663 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-22-017895 · form4.xml · derivative · entry 2

Burton Paul · CIK 0001869869 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,663

Underlying: Common Stock · 3,663 shares

Expires not disclosed

F2 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award will vest on June 16, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

F2 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award will vest on June 16, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 16:03 UTC
Burton PaulChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 6,902 $0.00 Strike: $121.08 $0.00
Disclosure

SEC source: 0001127602-22-017895 · form4.xml · derivative · entry 1

Burton Paul · CIK 0001869869 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,902

Underlying: Common Stock · 6,902 shares

Expires 2032-06-16

F1 · derivative.exercise_date: 25% of this option will vest and become exercisable on June 16, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · derivative · entry 15

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,307,155

Underlying: Common Stock · 40,000 shares

Expires 2023-08-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F15 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 2,800 $130.63 $365,764.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 8

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,411,946

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.34 to $131.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 9,206 $129.87 $1,195,583.22
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 7

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,414,746

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.33 to $130.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 9,451 $128.84 $1,217,666.84
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 6

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,423,952

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.32 to $129.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 6,225 $127.88 $796,053.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 5

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,433,403

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.30 to $128.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 4,279 $126.75 $542,363.25
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 4

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,439,628

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.27 to $127.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 5,659 $125.87 $712,298.33
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 3

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,443,907

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.26 to $126.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
SaleCommon Stock 2,380 $124.63 $296,619.40
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 2

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,449,566

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.25 to $125.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:09 UTC
Bancel StephaneDirector · Chief Executive Officer
Exercise / conversionCommon Stock 40,000 $0.99 $39,600.00
Disclosure

SEC source: 0001127602-22-017762 · form4.xml · nonDerivative · entry 1

Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,451,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as last amended on March 15, 2022, and as further described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 24, 2022.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 22:55 UTC
Hoge StephenPresident
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0001127602-22-017491 · form4.xml · derivative · entry 7

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,972

Underlying: Common Stock · 5,000 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 22:55 UTC
Hoge StephenPresident
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $10.90 $0.00
Disclosure

SEC source: 0001127602-22-017491 · form4.xml · derivative · entry 6

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,972

Underlying: Common Stock · 5,000 shares

Expires 2026-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

F3 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 22:55 UTC
Hoge StephenPresident
SaleCommon Stock 10,000 $123.00 $1,230,000.00
Disclosure

SEC source: 0001127602-22-017491 · form4.xml · nonDerivative · entry 3

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,624,231

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 22:55 UTC
Hoge StephenPresident
Exercise / conversionCommon Stock 5,000 $10.90 $54,500.00
Disclosure

SEC source: 0001127602-22-017491 · form4.xml · nonDerivative · entry 2

Hoge Stephen · CIK 0001760669 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,634,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.